Jamilah Meghji1,2, Gilbert Nadeau3, Kourtney J Davis4, Duolao Wang2, Moffat J Nyirenda5, Stephen B Gordon2,6, Kevin Mortimer2,6. 1. 1 Wellcome Trust Liverpool Glasgow Centre for Global Health Research, University of Liverpool, Liverpool, United Kingdom. 2. 2 Liverpool School of Tropical Medicine, Liverpool, United Kingdom. 3. 3 Medical Affairs, GSK Canada, Mississauga, Ontario, Canada. 4. 4 Worldwide Epidemiology, GSK R&D, Collegeville, Pennsylvania. 5. 5 London School of Hygiene & Tropical Medicine, London, United Kingdom; and. 6. 6 Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Abstract
RATIONALE: Noncommunicable diseases are major causes of morbidity and mortality in sub-Saharan Africa (sSA). Valid burden of disease estimates are lacking for noncommunicable lung disease in sSA. OBJECTIVES: We performed a community-based survey to determine the prevalence of chronic lung disease among adults 18 years or older in Malawi, using American Thoracic Society standard spirometry, internationally validated respiratory symptom and exposure questionnaires, and an assessment of HIV status. METHODS: An age- and sex-stratified random sample of 2,000 adults was taken from the population of the Chilomoni district of Blantyre, Malawi. Fieldworkers collected questionnaire data, conducted HIV testing, and performed pre- and post-bronchodilator spirometry on eligible participants. Survey-weighted population prevalence estimates of respiratory symptoms and spirometric abnormalities were computed, and bivariate and multivariable regression were used to identify associated variables. MEASUREMENTS AND MAIN RESULTS: Questionnaire data, HIV status, and standard spirometry were obtained from 1,059, 933, and 749 participants, respectively. Current respiratory symptoms, exposure to biomass, and ever-smoking were reported by 11.8, 85.2, and 10.4% of participants, respectively. HIV prevalence was 24.2%. Moderate to severe airway obstruction was seen in 3.6%. The prevalence of spirometric restriction was 38.6% using National Health and Nutrition Examination Survey III reference ranges and 9.0% using local reference ranges. Age was positively associated with obstruction, whereas low body mass index was associated with restriction. CONCLUSIONS: More than 40% of the Malawian adults in our urban population sample had abnormal lung function (mostly restrictive) in the context of widespread exposure to biomass smoke and a high prevalence of HIV. These findings potentially have major public health implications for Malawi and the broader sSA region.
RATIONALE: Noncommunicable diseases are major causes of morbidity and mortality in sub-Saharan Africa (sSA). Valid burden of disease estimates are lacking for noncommunicable lung disease in sSA. OBJECTIVES: We performed a community-based survey to determine the prevalence of chronic lung disease among adults 18 years or older in Malawi, using American Thoracic Society standard spirometry, internationally validated respiratory symptom and exposure questionnaires, and an assessment of HIV status. METHODS: An age- and sex-stratified random sample of 2,000 adults was taken from the population of the Chilomoni district of Blantyre, Malawi. Fieldworkers collected questionnaire data, conducted HIV testing, and performed pre- and post-bronchodilator spirometry on eligible participants. Survey-weighted population prevalence estimates of respiratory symptoms and spirometric abnormalities were computed, and bivariate and multivariable regression were used to identify associated variables. MEASUREMENTS AND MAIN RESULTS: Questionnaire data, HIV status, and standard spirometry were obtained from 1,059, 933, and 749 participants, respectively. Current respiratory symptoms, exposure to biomass, and ever-smoking were reported by 11.8, 85.2, and 10.4% of participants, respectively. HIV prevalence was 24.2%. Moderate to severe airway obstruction was seen in 3.6%. The prevalence of spirometric restriction was 38.6% using National Health and Nutrition Examination Survey III reference ranges and 9.0% using local reference ranges. Age was positively associated with obstruction, whereas low body mass index was associated with restriction. CONCLUSIONS: More than 40% of the Malawian adults in our urban population sample had abnormal lung function (mostly restrictive) in the context of widespread exposure to biomass smoke and a high prevalence of HIV. These findings potentially have major public health implications for Malawi and the broader sSA region.
Entities:
Keywords:
COPD; biomass; lung function; noncommunicable disease; sub-Saharan Africa
Authors: A Sonia Buist; William M Vollmer; Sean D Sullivan; Kevin B Weiss; Todd A Lee; Ana M B Menezes; Robert O Crapo; Robert L Jensen; Peter G J Burney Journal: COPD Date: 2005-06 Impact factor: 2.409
Authors: Richard Hooper; Peter Burney; William M Vollmer; Mary Ann McBurnie; Thorarinn Gislason; Wan C Tan; Anamika Jithoo; Ali Kocabas; Tobias Welte; A Sonia Buist Journal: Eur Respir J Date: 2011-12-19 Impact factor: 16.671
Authors: Shungu S Munyati; Temba Dhoba; Evelyn D Makanza; Stanley Mungofa; Maureen Wellington; Junior Mutsvangwa; Lovemore Gwanzura; James Hakim; Morgan Nyakabau; Peter R Mason; Valerie Robertson; Simba Rusakaniko; Anthony E Butterworth; Elizabeth L Corbett Journal: Clin Infect Dis Date: 2005-05-12 Impact factor: 9.079
Authors: A Sonia Buist; Mary Ann McBurnie; William M Vollmer; Suzanne Gillespie; Peter Burney; David M Mannino; Ana M B Menezes; Sean D Sullivan; Todd A Lee; Kevin B Weiss; Robert L Jensen; Guy B Marks; Amund Gulsvik; Ewa Nizankowska-Mogilnicka Journal: Lancet Date: 2007-09-01 Impact factor: 79.321
Authors: Helen Ayles; Monde Muyoyeta; Elizabeth Du Toit; Ab Schaap; Sian Floyd; Musonda Simwinga; Kwame Shanaube; Nathaniel Chishinga; Virginia Bond; Rory Dunbar; Petra De Haas; Anelet James; Nico C Gey van Pittius; Mareli Claassens; Katherine Fielding; Justin Fenty; Charalampos Sismanidis; Richard J Hayes; Nulda Beyers; Peter Godfrey-Faussett Journal: Lancet Date: 2013-08-01 Impact factor: 79.321
Authors: Peter Burney; Anamika Jithoo; Bernet Kato; Christer Janson; David Mannino; Ewa Nizankowska-Mogilnicka; Michael Studnicka; Wan Tan; Eric Bateman; Ali Koçabas; William M Vollmer; Thorarrin Gislason; Guy Marks; Parvaiz A Koul; Imed Harrabi; Louisa Gnatiuc; Sonia Buist Journal: Thorax Date: 2013-12-18 Impact factor: 9.139
Authors: Engi F Attia; Elizabeth Maleche-Obimbo; T Eoin West; Lilian Ndukwe-Wambutsi; Catherine Kiptinness; Anthony Cagle; Christine J McGrath; Celestine K Mugambi; Neveen G El Antouny; Sherry Eskander; Michael H Chung; Kristina Crothers Journal: AIDS Date: 2018-06-19 Impact factor: 4.177
Authors: Daniel O Obaseki; Gregory E Erhabor; Olayemi F Awopeju; Olufemi O Adewole; Bamidele O Adeniyi; Emerita A Sonia Buist; Peter G Burney Journal: Ann Am Thorac Soc Date: 2017-05
Authors: Crystal M North; Joseph G Allen; Samson Okello; Ruth Sentongo; Bernard Kakuhikire; Edward T Ryan; Alexander C Tsai; David C Christiani; Mark J Siedner Journal: Lung Date: 2017-12-19 Impact factor: 2.584
Authors: Jamilah Meghji; Maia Lesosky; Elizabeth Joekes; Peter Banda; Jamie Rylance; Stephen Gordon; Joseph Jacob; Harmien Zonderland; Peter MacPherson; Elizabeth L Corbett; Kevin Mortimer; Stephen Bertel Squire Journal: Thorax Date: 2020-02-26 Impact factor: 9.139